EPA-0808 - Efficacy and safety of adjunctive brexpiprazole (opc-34712) in major depressive disorder (MDD): A phase iii, randomized, placebo-controlled study
Thase, M.E., Hobart, M., Augustine, C., Youakim, J., Zhang, P., Hefting, N., McQuade, R.D., Carson, W., Nyilas, M., Sanchez, R.Volume:
29
Year:
2014
Language:
english
Journal:
European Psychiatry
DOI:
10.1016/S0924-9338(14)78150-7
File:
PDF, 59 KB
english, 2014